Uterine carcinosarcoma in association with tamoxifen therapy
- 1 June 1997
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 104 (6) , 748-750
- https://doi.org/10.1111/j.1471-0528.1997.tb11992.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus?International Journal of Gynecologic Cancer, 1995
- Uterine Malignant Mixed Mullerian Tumor in a Patient on Long-Term Tamoxifen Therapy for Breast CancerGynecologic Oncology, 1993
- Role of Prolonged Stimulation of Tamoxifen Therapy in the Etiology of Endometrial SarcomasGynecologic Oncology, 1993
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapyGynecologic Oncology, 1992
- Role of prolonged excessive estrogen stimulation in the pathogenesis of endometrial sarcomas: Two cases and a review of the literatureGynecologic Oncology, 1990
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUMThe Lancet, 1989
- Biology and mode of action of pure antioestrogensJournal of Steroid Biochemistry, 1988
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- ŒSTROGEN USE AND SURVIVAL IN ENDOMETRIAL CANCERThe Lancet, 1980